Viemed Healthcare (VMD) EBITDA Margin (2018 - 2026)
Viemed Healthcare (VMD) posted EBITDA Margin of 5.7% for Q1 2026, down 48.16% on a QoQ basis from 10.99% in Q4 2025, and down 80.0% year-over-year from 28.48% in Q1 2025.
Viemed Healthcare (VMD) EBITDA Margin (2018 - 2026) Analysis & Trends
Viemed Healthcare's EBITDA Margin history runs 9 years deep, the most recent figure standing at 5.7% for Q1 2026.
- Quarterly EBITDA Margin fell 80.0% year-over-year to 5.7% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.17% (down 23.0% YoY) and the FY2025 annual result came in at 8.49%, up 51.0% from the prior year.
- EBITDA Margin was 5.7% for Q1 2026 at Viemed Healthcare, down from 10.99% in the prior quarter.
- Across five years, EBITDA Margin topped out at 10.99% in Q4 2025 and bottomed at 3.73% in Q2 2022.
- A 5-year average of 7.62% and a median of 7.7% in 2022 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin slumped 674 bps — and 2023, when it surged 444 bps.
- Viemed Healthcare's EBITDA Margin stood at 10.06% in 2022, then rose by 4 bps to 10.42% in 2023, then grew by 2 bps to 10.63% in 2024, then grew by 3 bps to 10.99% in 2025, then sank by 48 bps to 5.7% in 2026.
- Business Quant data shows VMD's EBITDA Margin at 5.7% in Q1 2026, 10.99% in Q4 2025, and 7.85% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 5.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.70% |
| Dec 31, 2025 | 10.99% |
| Sep 30, 2025 | 7.85% |
| Jun 30, 2025 | 8.08% |
| Mar 31, 2025 | 6.50% |
| Dec 31, 2024 | 10.63% |
| Sep 30, 2024 | 9.70% |
| Jun 30, 2024 | 6.58% |
| Mar 31, 2024 | 4.36% |
| Dec 31, 2023 | 10.42% |
| Sep 30, 2023 | 9.36% |
| Jun 30, 2023 | 7.39% |
| Mar 31, 2023 | 5.50% |
| Dec 31, 2022 | 10.06% |
| Sep 30, 2022 | 4.92% |
| Jun 30, 2022 | 3.73% |
| Mar 31, 2022 | 7.70% |
| Dec 31, 2021 | 15.32% |
| Sep 30, 2021 | 10.69% |
| Jun 30, 2021 | 10.48% |